• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Anixa Biosciences(ANIX.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Sep11
Anixa Biosciences released FY2025 9 Months earnings on September 10, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.255
03:00
Anixa Biosciences released FY2025 Q3 earnings on September 10, 2025 (EST), with actual EPS of USD -0.0695 (forecasted EPS USD -0.0866)
03:00
Jul15
Anixa Biosciences CEO Buys Company Stock
08:43
Jun23
Anixa Biosciences Launches Fourth Phase Clinical Trial for Recurrent Ovarian Cancer CAR-T Treatment
12:01
Jun20
Anixa Announces Investor Webcast on June 26
11:52
Jun9
Anixa to Present Ovarian Cancer CAR-T Therapy Clinical Trial Results
12:01

Schedules & Filings

Schedules
Filings
Sep10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -2.258 M, EPS -0.0695

May28
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -2.79 M, EPS -0.0866

Mar11
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -3.184 M, EPS -0.0988

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
9.530
+132.44%
+5.430
ANGH
3.770
+62.50%
+1.450
WTO
1.020
+61.09%
+0.387
ESHAR
0.2500
+47.06%
+0.080
NCL
0.2731
+40.77%
+0.079
FGMCR
0.5500
+33.50%
+0.138
ESHA
19.180
+33.38%
+4.800
IPEXR
0.8000
+31.97%
+0.194
RDACR
0.2400
+26.32%
+0.050
DVLT
0.6521
+26.25%
+0.136
View More